综述与进展

亲核氟源参与的芳环氟-18标记反应研究进展

  • 朱源 ,
  • 陈乐园 ,
  • 侯文彬 ,
  • 李祎亮
展开
  • 1 中国医学科学院北京协和医学院放射医学研究所 天津市放射医学与分子核医学重点实验室 天津 300192

收稿日期: 2020-10-21

  修回日期: 2020-12-29

  网络出版日期: 2021-02-07

基金资助

中国医学科学院医学与健康科技创新工程(2016-I2M-3-022); 中国医学科学院医学与健康科技创新工程(2017-I2M-3-019); 中央高校基本科研业务费专项资金(3332018117); 天津市科技计划(18ZXXYSY00110)

Recent Progress in Nucleophilic Fluoride Mediated Fluorine-18 Labeling of Arenes and Heteroarenes

  • Yuan Zhu ,
  • Leyuan Chen ,
  • Wenbin Hou ,
  • Yiliang Li
Expand
  • 1 Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Peking Union Medical College & Chinese Academy of Medical Sciences, Tianjin 300192
* Corresponding authors. E-mail: ;

Received date: 2020-10-21

  Revised date: 2020-12-29

  Online published: 2021-02-07

Supported by

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(2016-I2M-3-022); Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(2017-I2M-3-019); Fundamental Research Funds for the Central Universities(3332018117); Science and Technology Project of Tianjin of China(18ZXXYSY00110)

摘要

氟18是用于临床和临床前研究的正电子发射计算机断层扫描(PET)放射性药物中最常用的放射性同位素, 至今已发现发展出多种标记方法. 亲核性18F氟源由于易于操作且具有高放射性比活度, 在氟标记反应中得到广泛应用. 同时, 引入氟原子可调节药物分子的空间构象和电性, 也能影响其极性、亲脂性和解离常数等药物代谢动力学参数. 芳香环本身代谢稳定性好, 是理想的氟标记载体. 亲核型氟源参与的芳香环氟-18标记反应为放射性药物的标记, 具有高效、操作简便、反应条件温和及原子经济性等优点, 为氟-18标记提供了一条新途径. 根据标记前体结构的不同, 综述了近年来亲核型氟源参与的芳香环氟-18标记方法领域研究进展, 同时探讨了部分反应的机理, 并对本领域未来发展进行了展望.

本文引用格式

朱源 , 陈乐园 , 侯文彬 , 李祎亮 . 亲核氟源参与的芳环氟-18标记反应研究进展[J]. 有机化学, 2021 , 41(5) : 1774 -1788 . DOI: 10.6023/cjoc202010030

Abstract

Fluorine-18 is the most frequently used radioisotope in positron emission tomography radiopharmaceuticals for both clinical and preclinical researches. A variety of labeling methodologies have also been developed in recent years. For most purposes, nucleophilic 18F-fluoride is preferentially used for 18F-labeling because this reagent is easy to handle and made available with high specific activity. Meanwhile, fluorine substitution has also served the purpose of modulating conformational and stereoelectronic properties, and favorably influences pharmacokinetic parameters such as polarity, lipophilicity and pKa values. Arenes and heteroarenes are privileged candidates for 18F-incorporation as they are metabolically robust and therefore widely used for 18F-labeling. Nucleophilic fluoride mediated fluorine-18 labeling reaction has emerged as a promising green and efficient synthetic tool and provides a novel approach for 18F-labeling. The recent developments in nucleophilic fluoride mediated fluorine-18 labeling of arenes and heteroarenes are summarized on the basis of different labeling precursor, including phenols, aryl iodoniums, aryl sulfoniums, aromatic metallic compounds and C(sp2)—H bond. The scope of labeling substrate, some application for radiopharmaceuticals and mechanism of several reactions are also discussed.

参考文献

[1]
Piel, M.; Vernaleken, I.; Rosch, F. J. Med. Chem. 2014, 57(22),9232.
[2]
Matthews, P. M.; Rabiner, E. A.; Passchier, J.; Gunn, R. N. Br. J. Clin. Pharmacol. 2012, 73(2),175.
[3]
Xiong, K. L.; Yang, Q. W.; Gong, S. G.; Zhang, W. G. Nucl. Med. Commun. 2010, 31(1),4.
[4]
Dobrucki, L. W.; Sinusas, A. J. Nat. Rev. Cardiol 2010, 7(1),38.
[5]
Ametamey, S. M.; Honer, M.; Schubiger, P. A. Chem. Rev. 2008, 108(5),1501.
[6]
Fernandez, I.; Frenking, G.; Uggerud, E. J. Org. Chem. 2010, 75(9),2971.
[7]
Neumann, C. N.; Hooker, J. M.; Ritter, T. Nature 2016, 534(7607),369.
[8]
Beyzavi, M. H.; Mandal, D.; Strebl, M. G.; Neumann, C. N.; D'Amato, E. M.; Chen, J.; Hooker, J. M.; Ritter, T. ACS Cent. Sci. 2017, 3(9),944.
[9]
Gao, Z.; Lim, Y. H.; Tredwell, M.; Li, L.; Verhoog, S.; Hopkinson, M.; Kaluza, W.; Collier, T. L.; Passchier, J.; Huiban, M.; Gouverneur, V. Angew. Chem. Int. Ed. 2012, 51(27),6733.
[10]
Mu, L.; Fischer, C. R.; Holland, J. P.; Becaud, J.; Schubiger, P. A.; Schibli, R.; Ametamey, S. M.; Graham, K.; Stellfeld, T.; Dinkelborg, L. M.; Lehmann, L. Eur. J. Org. Chem. 2012,889.
[11]
Sander, K.; Gendron, T.; Yiannaki, E.; Cybulska, K.; Kalber, T. L.; Lythgoe, M. F.; Arstad, E. Sci. Rep. 2015, 5, 9941.
[12]
Chun, J. H.; Morse, C. L.; Chin, F. T.; Pike, V. W. Chem. Commun. 2013, 49(21),2151.
[13]
Pike, V. W.; Aigbirhio, F. I. J. Chem. Soc., hem. Commun. 1995.
[14]
Ross, T. L.; Ermert, J.; Hocke, C.; Coenen, H. H. J. Am. Chem. Soc. 2007, 129(25),8018.
[15]
Chun, J. H.; Lu, S.; Lee, Y. S.; Pike, V. W. J. Org. Chem. 2010, 75(10),3332.
[16]
Yuan, Z.; Cheng, R.; Chen, P.; Liu, G.; Liang, S. H. Angew Chem. Int. Ed. 2016, 55, 11882.
[17]
Ichiishi, N.; Brooks, A. F.; Topczewski, J. J.; Rodnick, M. E.; Sanford, M. S.; Scott, P. J. Org. Lett. 2014, 16(12),3224.
[18]
McCammant, M. S.; Thompson, S.; Brooks, A. F.; Krska, S. W.; Scott, P. J. H.; Sanford, M. S. Org. Lett. 2017, 19(14),3939.
[19]
Cardinale, J.; Ermert, J.; Humpert, S.; Coenen, H. H. RSC Adv. 2014, 4(33),17293.
[20]
Rotstein, B. H.; Stephenson, N. A.; Vasdev, N.; Liang, S. H. Nat. Commun. 2014, 5, 4365.
[21]
Rotstein, B. H.; Wang, L.; Liu, R. Y.; Patteson, J.; Kwan, E. E.; Vasdev, N.; Liang, S. H. Chem. Sci. 2016, 7(7),4407.
[22]
Jakobsson, J. E.; Gronnevik, G.; Riss, P. J. Chem. Commun. 2017, 53(96),12906.
[23]
Haskali, M. B.; Telu, S.; Lee, Y. S.; Morse, C. L.; Lu, S.; Pike, V. W. J. Org. Chem. 2016, 81(1),297.
[24]
Ye, Y.; Schimler, S. D.; Hanley, P. S.; Sanford, M. S. J. Am. Chem. Soc. 2013, 135(44),16292.
[25]
Tredwell, M.; Preshlock, S. M.; Taylor, N. J.; Gruber, S.; Huiban, M.; Passchier, J.; Mercier, J.; Genicot, C.; Gouverneur, V. Angew Chem. Int. Ed. 2014, 53(30),7751.
[26]
Zhang, Z.; Zhang, C.; Lau, J.; Colpo, N.; Benard, F.; Lin, K. S. J. Labelled Comp. Radiopharm. 2016, 59(11),467.
[27]
Zhang, Z.; Lau, J.; Zhang, C.; Colpo, N.; Nocentini, A.; Supuran, C. T.; Benard, F.; Lin, K. S. J. Enzyme Inhib. Med. Chem. 2017, 32(1),722.
[28]
Blevins, D. W.; Kabalka, G. W.; Osborne, D. R.; Akula, M. R. Nat. Sci. 2018, 10(3),125.
[29]
Elie, J.; Vercouillie, J.; Arlicot, N.; Lemaire, L.; Bidault, R.; Bodard, S.; Hosselet, C.; Deloye, J. B.; Chalon, S.; Emond, P.; Guilloteau, D.; Buron, F.; Routier, S. J. Enzyme Inhib. Med. Chem. 2019, 34(1),1.
[30]
Guibbal, F.; Meneyrol, V.; Ait-Arsa, I.; Diotel, N.; Patche, J.; Veeren, B.; Benard, S.; Gimie, F.; Yong-Sang, J.; Khantalin, I.; Veerapen, R.; Jestin, E.; Meilhac, O. ACS Med. Chem. Lett. 2019, 10(5),743.
[31]
Mossine, A. V.; Tanzey, S. S.; Brooks, A. F.; Makaravage, K. J.; Ichiishi, N.; Miller, J. M.; Henderson, B. D.; Skaddan, M. B.; Sanford, M. S.; Scott, P. J. H. Org. Biomol. Chem. 2019, 17(38),8701.
[32]
Basuli, F.; Zhang, X.; Blackman, B.; White, M. E.; Jagoda, E. M.; Choyke, P. L.; Swenson, R. E. Molecules 2019, 24, 2389.
[33]
Clemente, G. S.; Zarganes-Tzitzikas, T.; D?mling, A. H.; Elsinga, P. Molecules 2019, 24, 4210.
[34]
Lahdenpohja, S. O.; Rajala, N. A.; Rajander, J.; Kirjavainen, A. K. EJNMMI Radiopharm. Chem. 2019, 4, 28.
[35]
Yuan, G.; Shoup, T. M.; Moon, S.-H.; Brownell, A.-L. RSC Adv. 2020, 10(42),25223.
[36]
Zhang, B.; Fraser, B. H.; Klenner, M. A.; Chen, Z.; Liang, S. H.; Massi, M.; Robinson, A. J.; Pascali, G. Chemistry 2019, 25(32),7613.
[37]
Preshlock, S.; Calderwood, S.; Verhoog, S.; Tredwell, M.; Huiban, M.; Hienzsch, A.; Gruber, S.; Wilson, T. C.; Taylor, N. J.; Cailly, T.; Schedler, M.; Collier, T. L.; Passchier, J.; Smits, R.; Mollitor, J.; Hoepping, A.; Mueller, M.; Genicot, C.; Mercier, J.; Gouverneur, V. Chem. Commun. 2016, 52(54),8361.
[38]
Taylor, N. J.; Emer, E.; Preshlock, S.; Schedler, M.; Tredwell, M.; Verhoog, S.; Mercier, J.; Genicot, C.; Gouverneur, V. J. Am. Chem. Soc. 2017, 139(24),8267.
[39]
Mossine, A. V.; Brooks, A. F.; Makaravage, K. J.; Miller, J. M.; Ichiishi, N.; Sanford, M. S.; Scott, P. J. Org. Lett. 2015, 17(23),5780.
[40]
Zischler, J.; Kolks, N.; Modemann, D.; Neumaier, B.; Zlatopolskiy, B. D. Chemistry 2017, 23(14),3251.
[41]
Zhang, X.; Basuli, F.; Swenson, R. E. J. Labelled Comp. Radiopharm. 2019, 62(3),139.
[42]
Wilson, T. C.; Xavier, M. A.; Knight, J.; Verhoog, S.; Torres, J. B.; Mosley, M.; Hopkins, S. L.; Wallington, S.; Allen, P. D.; Kersemans, V.; Hueting, R.; Smart, S.; Gouverneur, V.; Cornelissen, B. J. Nucl. Med. 2019, 60(4),504.
[43]
Guibbal, F.; Isenegger, P. G.; Wilson, T. C.; Pacelli, A.; Mahaut, D.; Sap, J. B. I.; Taylor, N. J.; Verhoog, S.; Preshlock, S.; Hueting, R.; Cornelissen, B.; Gouverneur, V. Nat. Protoc. 2020, 15(4),1525.
[44]
Narayanam, M. K.; Ma, G.; Champagne, P. A.; Houk, K. N.; Murphy, J. M. Angew. Chem. Int. Ed. 2017, 56(42),13006.
[45]
Lee, E.; Kamlet, A. S.; Powers, D. C.; Neumann, C. N.; Boursalian, G. B.; Furuya, T.; Choi, D. C.; Hooker, J. M.; Ritter, T. Science 2011, 334(6056),639.
[46]
Kamlet, A. S.; Neumann, C. N.; Lee, E.; Carlin, S. M.; Moseley, C. K.; Stephenson, N.; Hooker, J. M.; Ritter, T. PLoS One 2013, 8(3),e59187.
[47]
Brandt, J. R.; Lee, E.; Boursalian, G. B.; Ritter, T. Chem. Sci. 2014, 5(1)
[48]
Lee, E.; Hooker, J. M.; Ritter, T. J. Am. Chem. Soc. 2012, 134(42),17456.
[49]
Ren, H.; Wey, H. Y.; Strebl, M.; Neelamegam, R.; Ritter, T.; Hooker, J. M. ACS Chem. Neurosci. 2014, 5(7),611.
[50]
Gamache, R. F.; Waldmann, C.; Murphy, J. M. Org. Lett. 2016, 18(18),4522.
[51]
Makaravage, K. J.; Brooks, A. F.; Mossine, A. V.; Sanford, M. S.; Scott, P. J. H. Org. Lett. 2016, 18(20),5440.
[52]
Truong, T.; Klimovica, K.; Daugulis, O. J. Am. Chem. Soc. 2013, 135(25),9342.
[53]
Lee, S. J.; Makaravage, K. J.; Brooks, A. F.; Scott, P. J. H.; Sanford, M. S. Angew. Chem. Int. Ed. 2019, 58(10),3119.
[54]
Chen, W.; Huang, Z.; Tay, N. E. S.; Giglio, B.; Wang, M.; Wang, H.; Wu, Z.; Nicewicz, D. A.; Li, Z. Science 2019, 364(6446),1170.
文章导航

/